(UEF5) UBS MSCI Emerging Markets - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1048313891

UEF5: ETF, Emerging, Markets, ESG, Equity

UBS MSCI Emerging Markets Socially Responsible UCITS A-dis (XETRA:UEF5) is an exchange-traded fund (ETF) designed to track the performance of the Morningstar EM TME NR USD Index. The fund focuses on socially responsible investments within emerging markets, aligning with environmental, social, and governance (ESG) criteria. Listed on XETRA, it offers exposure to a diversified portfolio of emerging market equities, making it a popular choice for investors seeking global diversification and ESG alignment. UBS, a global banking giant, sponsors the ETF, ensuring robust operational backing and oversight.

From a technical standpoint, the ETF shows a last price of 12.03, with a 20-day average volume of 37,153. The short-term trend, as indicated by the SMA 20 (11.78), suggests the price is slightly above its recent average, signaling mild upward momentum. However, the SMA 50 (12.56) and SMA 200 (12.62) are above the current price, indicating potential resistance levels in the medium to long term. The ATR of 0.26 reflects moderate volatility, suggesting relatively stable price movements over the past 20 days.

Fundamentally, the ETF manages an impressive AUM of 2,045.60 million EUR, underscoring its popularity and liquidity in the market. This scale typically allows for efficient tracking of the underlying index and minimizes deviations from its performance. As an ETF focused on socially responsible investing, it attracts investors prioritizing sustainability without compromising on returns.

3-Month Forecast: Based on , the ETF is expected to face resistance near the SMA 50 (12.56) and SMA 200 (12.62) levels, potentially capping upside movements. Support is likely to hold around the SMA 20 (11.78). The ATR of 0.26 suggests volatility will remain contained, with price fluctuations expected to stay within a narrow range. From a perspective, emerging market equities may experience increased flows if global risk sentiment improves, driven by easing inflation and stabilizing interest rates. However, geopolitical risks and currency volatility remain key downside risks.

Additional Sources for UEF5 ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

UEF5 ETF Overview

Market Cap in USD 2,298m
Category Global Emerging Markets Equity
TER 0.20%
IPO / Inception 2014-09-04

UEF5 ETF Ratings

Growth Rating 26.2
Fundamental -
Dividend Rating 46.0
Rel. Strength -13.9
Analysts -
Fair Price Momentum 11.65 EUR
Fair Price DCF -

UEF5 Dividends

Dividend Yield 12m 2.48%
Yield on Cost 5y 3.44%
Annual Growth 5y -1.60%
Payout Consistency 93.5%
Payout Ratio %

UEF5 Growth Ratios

Growth Correlation 3m 3%
Growth Correlation 12m 41.4%
Growth Correlation 5y 13.4%
CAGR 5y 6.62%
CAGR/Max DD 5y 0.26
Sharpe Ratio 12m 0.98
Alpha 1.81
Beta 0.718
Volatility 14.68%
Current Volume 28.7k
Average Volume 20d 35.2k
What is the price of UEF5 shares?
As of June 01, 2025, the stock is trading at EUR 12.79 with a total of 28,688 shares traded.
Over the past week, the price has changed by -1.54%, over one month by +6.34%, over three months by -5.79% and over the past year by +11.16%.
Is UBS MSCI Emerging Markets a good stock to buy?
Neither. Based on ValueRay´s Analyses, UBS MSCI Emerging Markets is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 26.21 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UEF5 is around 11.65 EUR . This means that UEF5 is currently overvalued and has a potential downside of -8.91%.
Is UEF5 a buy, sell or hold?
UBS MSCI Emerging Markets has no consensus analysts rating.
What are the forecasts for UEF5 share price target?
According to our own proprietary Forecast Model, UEF5 UBS MSCI Emerging Markets will be worth about 13.3 in June 2026. The stock is currently trading at 12.79. This means that the stock has a potential upside of +4.07%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 13.3 4.1%